Variability in contrast agent uptake by different but similar stem cell types
Ashwini Ketkar-Atre,1 Tom Struys,1,2 Stefaan J Soenen,3 Ivo Lambrichts,2 Catherine M Verfaillie,4 Marcel De Cuyper,5 Uwe Himmelreich1 1Biomedical MRI/MoSAIC, Department of Imaging and Pathology, Biomedical Sciences Group, Katholieke Universiteit Leuven, Leuven, Belgium; 2Lab of Histology, Biomedical...
Guardado en:
Autores principales: | Ketkar-Atre A, Struys T, Soenen SJ, Lambrichts I, Verfaillie CM, De Cuyper M, Himmelreich U |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83a224ab64ca4f6da9c340e050a8f4d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging
por: D’Hollander A, et al.
Publicado: (2016) -
Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade
por: Michael Haimerl, et al.
Publicado: (2021) -
Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes
por: Garcia Ribeiro RS, et al.
Publicado: (2019) -
Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging
por: Roxanne Hachani, et al.
Publicado: (2017) -
Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques
por: Ariza de Schellenberger A, et al.
Publicado: (2018)